TSX open
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • ✓200 free stock & ETF trades
  • ✓Unlimited commission-free trades on 180+ select ETFs
  • ✓Offer ends September 30, 2026
Stocks/NASDAQ/CAI

Caris Life Sciences, Inc. Common Stock (CAI : NASDAQ)

Common Stock

$0.02

USD

-30.61 (-99.93%)

Last updated: 2026-10-01

Follow CAI

CAI

Caris Life Sciences, Inc. Common Stock

Source:WealthAwesomeWealthAwesome
↑ $3.77 (15.34%)
30 day period
$24.03$28.15$32.27Aug 20Sep 11Oct 1

Performance

1 Day

-7.44%

1 Week

-12.15%

1 Month

+14.41%

YTD

+58.73%

Key Statistics

Market Cap

$8.66B

52W High

$33.66

52W Low

$14.19

P/E Ratio

3.20

50 Day MA

$23.64

200 Day MA

$21.18

Beta

-

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↑Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
10/1/2026$30.60$30.96$28.29$28.35$28.354,407,375
9/30/2026$31.40$32.04$30.60$30.63$30.632,928,659
9/29/2026$31.64$32.33$30.82$31.55$31.553,691,265
9/28/2026$31.73$32.09$30.88$31.75$31.753,916,161
9/25/2026$32.65$32.77$31.59$31.98$31.982,919,200
9/24/2026$31.34$32.41$30.91$32.27$32.275,982,289
9/23/2026$31.12$32.89$31.10$31.65$31.654,355,681
9/22/2026$31.55$32.36$31.33$31.47$31.475,855,113
9/21/2026$30.23$30.71$29.97$30.65$30.656,028,739
9/18/2026$30.29$30.99$29.69$29.98$29.9814,722,900

Analyst Price Targets

Based on analyst covering CAI · as of Sep 23, 2026

📈

Wall Street analysts forecast CAI stock price to rise 140669.5% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

US$28.15

+140669.5% Upside

Previously US$27.54 on Sep 17, 2026

Current Price

US$0.02

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on CAI's historical volatility

HistoricalForecast68%95%
US$14.92US$27.29US$39.66US$52.03US$64.40US$76.77TodayJun 17Aug 11Oct 1Nov 13Dec 27Feb 8

30-Day Vol

65.9%

Annualized

90-Day Vol

70.7%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

US$33.89

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$30.09US$23.97 – US$37.77
60 trading daysUS$31.93US$23.15 – US$44.05
90 trading daysUS$33.89US$22.86 – US$50.26

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Caris Life Sciences, Inc. Common Stock

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.

Financials

Revenue (TTM)
$989.60M
EBITDA
$174.02M
Profit Margin
10.62%
ROE (TTM)
20.13%
EPS (Diluted)
9.58
Book Value
2.09

Classification

Sector
Health Care
Industry
Life Sciences Tools & Services
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About CAI.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
IFRXInflaRx N.V.$145.00+7955.56%
BGMQilian International Holding Group Limited$7.82+3005.64%
KUSTKustom Entertainment, Inc.$4.42+944.42%
SSMSono Group N.V.$2.21+97.32%
NXLNexalin Technology Inc.$7.55+76.40%
VEEAVeea Inc.$3.47+59.91%
RPGLRepublic Power Group Limited Class A Ordinary Shares$26.20+59.85%
XRPNArmada Acquisition Corp. II$23.43+42.87%

CAI.US news timeline

1 article covering CAI.US, most recent first

Latest

Why Caris Life Sciences, Inc. Common Stock stock plummeted yesterday

•Stocks

Advertisement